Literature DB >> 1221921

Proceedings: Ups and downs of indomethacin bioavailability.

P M Brooks, M A Bell, J J Walker, A C Kennedy, R D Sturrock, W C Dick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1221921      PMCID： PMC1006454          DOI： 10.1136/ard.34.5.465-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  The metabolism of indomethacin in man.

Authors:  D E Duggan; A F Hogans; K C Kwan; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

2.  Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis.

Authors:  P Lee; J Webb; J Anderson; W W Buchanan
Journal:  Br Med J       Date:  1973-06-23
  2 in total
  2 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Authors:  L O Eriksson; E Wåhlin-Boll; H Liedholm; P Seideman; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.